Abstract:Background: There are no population-based studies on the prognostic value of the preoperative aminotransferase-to-lymphocyte ratio (AALR) in predicting recurrence and survival in patients with colorectal cancer (CRC) who have undergone curative resection. Aim: This study explored the relationship between AALR and prognosis of CRC patients, specifically stage III CRC. Methods: Restricted Cubic Splines were used to evaluate the relationship between AALR and outcomes. The survival curve was generated using the Kaplan-Meier method and the log-rank test. COX regression analysis was used to identify the independent prognostic factors of CRC patients. Logistic regression analysis was used to assess the independent risk factors affecting sarcopenia and postoperative complications. Concordance index and calibration curves were used to evaluate the discriminative ability of the prognostic nomograms. Finally, according to a ratio of 7:3, the total population was randomized into two cohorts to validate the practicability of the prognostic nomograms. Results: In total, 1304 stage I-III CRC were enrolled in this study. There was a significant positive correlation between AALR and PFS/OS in CRC patients. The PFS/OS ratio of the high AALR group was significantly lower than that of the low AALR group. In the subgroup analysis, we found that the AALR significantly stratified the prognosis of patients with stage III CRC. A high AALR was still independently associated with poor PFS (HR = 1.335, 95% CI =1.075–1.657, p=0.009) and OS (HR = 1.382, 95% CI =1.139–1.677, p=0.001) in CRC patients. Variables with a value ≤ 0.05 in multivariable analysis were incorporated into the construction of prognostic nomograms for predicting 1-5 years PFS/OS of CRC patients. The results of the concordance index and calibration curves confirmed that these prognostic nomograms had a good prediction accuracy. In addition, we demonstrated the good predictive performance of these nomograms in a randomized internal validation cohort. Conclusion: AALR is an effective prognostic marker for predicting long-term outcomes and could provide a valuable reference for sarcopenia and postoperative complications in CRC patients. AALR-based nomograms have good predictive accuracy and can help to develop individualized risk stratification, follow-up, and treatment strategies for CRC patients.

Lectin from Agrocybe Aegerita As a Glycophenotype Probe for Evaluation of Progression and Survival in Colorectal Cancer.

Molecular Character of the Recombinant Antitumor Lectin from the Edible Mushroom Agrocybe Aegerita.

3’-Sulfo-TF Antigen Determined by GAL3ST2/ST3GAL1 Is Essential for Antitumor Activity of Fungal Galectin AAL/AAGL

Structural Basis for the Tumor Cell Apoptosis-Inducing Activity of an Antitumor Lectin from the Edible Mushroom Agrocybe Aegerita.

ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient's Response to Chemotherapies.

Glycan analysis of colorectal cancer samples reveals stage-dependent changes in CEA glycosylation patterns

Identification of EFEMP2 As a Serum Biomarker for the Early Detection of Colorectal Cancer with Lectin Affinity Capture Assisted Secretome Analysis of Cultured Fresh Tissues.

Serum IgG N-glycans Enable Early Detection and Early Relapse Prediction of Colorectal Cancer.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

PTH-82 Alcam, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer

Membrane Protein Glycanprofiling of Hepatocellular Carcinoma Cell with Different Metastastic Potential by Lectin Microarray*

Comparative serum glycoproteomics of non-metastatic and metastatic hepatocellular carcinoma by lectin affinity technology

Multiple Lectin Assays for Detecting Glyco-Alteration of Serum GP73 in Liver Diseases

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia

Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study

Lectin Array and Glycogene Expression Analyses of Ovarian Cancer Cell Line A2780 and Its Cisplatin-Resistant Derivate Cell Line A2780-cp

Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma

Multiple lectin assays in detecting glycol-alteration status of serum NRG1 in papillary thyroid cancer

AHCYL1 is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer.

Identification of N-glycan moiety of tumor marker by lectin microarray

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis